Lv31
246 积分 2025-08-20 加入
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
2小时前
待确认
Abstract 5554: Anti-human CTLA-4×TIGIT bispecific antibody: A novel immunotherapy specifically targeting tumor-infiltrating FOXP3+ regulatory T cells
6天前
已完结
Abstract 1803: GNP101, anti-HER2-IFN-β mutein immunocytokine, for the treatment of Trastuzumab deruxtecan-resistant HER2-positive cancers
6天前
已完结
GNP101, anti-HER2-IFN-β mutein immunocytokine, for the treatment of Trastuzumab deruxtecan-resistant HER2-positive cancers
11天前
已完结
Anti-human CTLA-4×TIGIT bispecific antibody: A novel immunotherapy specifically targeting tumor-infiltrating FOXP3+ regulatory T cells
11天前
已完结
ABN202, a TROP2-targeted IFN-β mutein fusion protein, overcomes ADC resistance and elicits durable CD8⁺ T cell-dependent antitumor immunity
11天前
已完结
ABN202, a TROP2-targeted IFN-beta mutein fusion protein, overcomes ADC resistance and elicits durable CD8# T cell-dependent antitumor immunity
11天前
已关闭
ARID1A mutation to define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer
18天前
已关闭
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC
18天前
已完结
Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia
21天前
已完结
皖公网安备34019202002308
